drugset / Trial / NCT02190058
Multiple Dose Study of DS-1971a
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This is a randomised, double-blind, placebo-controlled multiple dose study designed to explore the safety, tolerability and PK of DS-1971a following oral administration over 14 days to healthy male subjects.
Timeline
- Start
- 2014-07
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DS-1971 | Small molecule | 4650 mg | Oral |
Indications
No indication recorded.